Testing effectiveness (Phase 2)Study completedNCT02889328
What this trial is testing
Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs
Who this might be right for
Gastrointestinal Stromal Tumors (GISTs)
Asan Medical Center 25